Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- LPRO -16.7%, GRRR -3.4%
Other news:
- EE -6% (prices offering of 6,956,522 shares of common stock at $26.50 per share)
- AXSM -4% (topline results of Paradigm phase 3 proof-of-concept trial of Solriamfetol in major depressive disorder with and without excessive daytime sleepiness)
- DBVT -2.9% (to delay 10-K filing)
- KLIC -2.9% (winding down Electronics Assembly business)
- TVTX -2.8% (to present new FILSPARI data)
- DHC -2.1% (Closes $140 Million Mortgage Financing Secured by 14 SHOP Properties)
- STM -2% (sign GaN agreement with Innoscience)
- AVA -1.7% (requests price adjustment in Washington; files 2025 Natural Gas Integrated Resource Plan)
- TKR -1.3% (CEO departing; names interim CEO)
- ONON -1.3% (updates leadership structure)
- LPLA -1.1% (prices offering of 4,687,500 shares of common stock at $320.00 per share)
- CMPX -1.1% (Tovecimig meets primary endpoint in the ongoing randomized phase 2/3 study in patients with biliary tract cancer)